Merbarone: an antitumor agent entering c
โ
Alice Glover; Hoo G. Chun; Larry M. Kleinman; David A. Cooney; Jacqueline Plowma
๐
Article
๐
1987
๐
Springer US
๐
English
โ 454 KB
Merbarone was developed to clinical trial stage on the basis of its 'curative' activity against P388 and L1210 leukemias and moderate activity against B16 melanoma and M5076 sarcoma. Its activity appears to be schedule-dependent favoring a longer duration of administration. The mechanism of action o